Sculptor Capital LP - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2020$1,961,000
-28.7%
242,700
-9.8%
0.01%
-50.0%
Q3 2020$2,750,000
+681.2%
269,000
+411.4%
0.02%
+800.0%
Q2 2020$352,00052,6000.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Ibex Investors LLC 1,892,593$15,292,0006.10%
GAGNON SECURITIES LLC 281,080$2,271,0000.36%
DISCIPLINED GROWTH INVESTORS INC /MN 2,029,195$16,396,0000.32%
Annandale Capital, LLC 43,532$352,0000.29%
WOODWARD DIVERSIFIED CAPITAL, LLC 23,000$186,0000.12%
IRONWOOD INVESTMENT MANAGEMENT LLC 20,328$164,0000.10%
Claret Asset Management Corp 54,972$444,0000.09%
Migdal Insurance & Financial Holdings Ltd. 890,339$7,194,0000.08%
Shay Capital LLC 47,800$386,0000.08%
ARS Investment Partners, LLC 77,714$628,0000.08%
View complete list of REDHILL BIOPHARMA LTD shareholders